MBT Munich Biotechnology GmbH

Without a significant step-up in government efforts to encourage biotechnology, France risks losing the promising industry it has created to date. by Melanie A. Senior Although France's first biotech

Pitting liposomes against cancer Research into angiogenesis—the growth of new blood vessels—has become an important approach to finding new cancer treatments. But identifying compounds that target and

The stock-market hype is over—but the research and start-up activity is hotter than ever. It may have been the single greatest instance of bio-stock hype since the IPO of Genentech Inc. two decades

A preview of the emerging health care companies profiled in the current issue ofSTART-UP: Windhover's Review of Emerging Medical Ventures Grouped Start-Ups This month's profile group: Anti-Angiogenesi